PLAY PODCASTS
OKYO Pharma clears key FDA meeting for Urcosimod Phase 2b/3 Trial

OKYO Pharma clears key FDA meeting for Urcosimod Phase 2b/3 Trial

Proactive - Interviews for investors · Proactive Investors

January 28, 20265m 5s

Audio is streamed directly from the publisher (cdn.simplecast.com) as published in their RSS feed. Play Podcasts does not host this file. Rights-holders can request removal through the copyright & takedown page.